ST Pharm Co.Ltd (237690) - Total Liabilities

Latest as of December 2025: ₩189.56 Billion KRW ≈ $128.46 Million USD

Based on the latest financial reports, ST Pharm Co.Ltd (237690) has total liabilities worth ₩189.56 Billion KRW (≈ $128.46 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

ST Pharm Co.Ltd - Total Liabilities Trend (2015–2025)

This chart illustrates how ST Pharm Co.Ltd's total liabilities have evolved over time, based on quarterly financial data. See 237690 working capital ratio to evaluate short-term liquidity relative to the company's equity base.

ST Pharm Co.Ltd Competitors by Total Liabilities

The table below lists competitors of ST Pharm Co.Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Stanmore Resources Ltd AU:SMR	Australia	AU$2.06 Billion
Fulltech Fiber Glass TWO:1815	Taiwan	NT$8.28 Billion
TECNOGLASS INC. DL-0001 F:7FH	Germany	€547.34 Million
EFORT Intelligent Equipment Co Ltd SHG:688165	China	CN¥1.94 Billion
EverCommerce Inc NASDAQ:EVCM	USA	$674.59 Million
China National Accord Medicines Corp Ltd SHE:000028	China	CN¥29.01 Billion
Target Hospitality Corp NASDAQ:TH	USA	$162.92 Million
Premier Investments Ltd AU:PMV	Australia	AU$432.10 Million

Liability Composition Analysis (2015–2025)

This chart breaks down ST Pharm Co.Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see ST Pharm Co.Ltd market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.26	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.32	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.24	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how ST Pharm Co.Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for ST Pharm Co.Ltd (2015–2025)

The table below shows the annual total liabilities of ST Pharm Co.Ltd from 2015 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩189.56 Billion ≈ $128.46 Million	-13.40%
2024-12-31	₩218.88 Billion ≈ $148.33 Million	-24.14%
2023-12-31	₩288.53 Billion ≈ $195.53 Million	+23.82%
2022-12-31	₩233.02 Billion ≈ $157.91 Million	+32.71%
2021-12-31	₩175.59 Billion ≈ $119.00 Million	+16.87%
2020-12-31	₩150.24 Billion ≈ $101.82 Million	+274.46%
2019-12-31	₩40.12 Billion ≈ $27.19 Million	+187.90%
2018-12-31	₩13.94 Billion ≈ $9.44 Million	-54.19%
2017-12-31	₩30.42 Billion ≈ $20.62 Million	-44.22%
2016-12-31	₩54.53 Billion ≈ $36.96 Million	-48.08%
2015-12-31	₩105.04 Billion ≈ $71.18 Million	--

About ST Pharm Co.Ltd

KQ:237690 Korea Pharmaceuticals

Market Cap

$1.61 Billion

₩2.37 Trillion KRW

Market Cap Rank

#7107 Global

#181 in Korea

Share Price

₩127000.00

Change (1 day)

-4.51%

52-Week Range

₩76500.00 - ₩168700.00

All Time High

₩168700.00